Incyte (INCY) Property, Plant & Equipment (Net) (2010 - 2026)
Powered by 
Analysis
Incyte (INCY) Property, Plant & Equipment (Net) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Property, Plant & Equipment (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | 1.67 Bn |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | 5.46 Bn |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | 1.96 Bn |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | 2.06 Bn |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | 34.61 Mn |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | 1.64 Bn |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | 554.14 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | - |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 107.22 Mn |
| 10 | Incyte | 25.65 Bn | 21.11 Bn | 1.57 Bn | 709.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 709.47 Mn |
| Mar 31, 2026 | 720.17 Mn |
| Dec 31, 2025 | 730.89 Mn |
| Sep 30, 2025 | 798.63 Mn |
| Jun 30, 2025 | 798.54 Mn |
| Mar 31, 2025 | 765.36 Mn |
| Dec 31, 2024 | 763.41 Mn |
| Sep 30, 2024 | 773.10 Mn |
| Jun 30, 2024 | 762.01 Mn |
| Mar 31, 2024 | 720.00 Mn |
| Dec 31, 2023 | 751.51 Mn |
| Sep 30, 2023 | 733.05 Mn |
| Jun 30, 2023 | 749.35 Mn |
| Mar 31, 2023 | 741.70 Mn |
| Dec 31, 2022 | 739.31 Mn |
| Sep 30, 2022 | 715.73 Mn |
| Jun 30, 2022 | 721.33 Mn |
| Mar 31, 2022 | 729.22 Mn |
| Dec 31, 2021 | 723.92 Mn |
| Sep 30, 2021 | 686.72 Mn |